BSE filing, BSE: 544205. Summary written from the filing by ALFA Finder's alert engine.
National Peroxide Ltd: key numbers
- Share price
- ₹510.60
- Market cap
- ₹293.4 Cr
- Revenue (annual)
- ₹289.7 Cr
- Net profit (annual)
- ₹5.82 Cr
- P/E (TTM)
- 17.5×Sector 34.5×
- Promoter holding
- 70.76%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from National Peroxide Ltd
All →National Peroxide Management Change
National Peroxide Limited announced CEO Rajiv Arora's resignation, effective November 2, 2026. Vinay Divakar Jayade will succeed him as CEO and Whole-Time Director, effective November 3, 2026.
National Peroxide Annual General Meeting
National Peroxide Ltd held its 6th Annual General Meeting on September 29, 2026. Members considered resolutions including financial statement adoption and a final dividend declaration.
National Peroxide Annual General Meeting
National Peroxide Limited has issued a notice for its 6th Annual General Meeting scheduled for September 29, 2026. The meeting will address financial statements, dividends, and director re-appointments.
National Peroxide Other Announcement
National Peroxide Limited issued a communication to shareholders providing the web-link to access the 6th AGM Notice and the Annual Report for FY 2025-26.
National Peroxide Annual Report
National Peroxide Limited has filed its Annual Report for FY 2025-26 and the notice for the upcoming 6th Annual General Meeting scheduled for September 29, 2026.
National Peroxide Management Change
National Peroxide Limited has re-appointed M/s. Kalyaniwalla & Mistry LLP as its Statutory Auditor for a term of 60 months.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.